Osteolytic change surrounding biodegradable cement restrictors used in total hip replacements mimicking malignancy

Sisith Ariyaratne, Mark Davies, Scott Evans, Steven James, Rajesh BotchuIndian 2024 · DOI

TL;DR

Biodegradable cement restrictors used in total hip replacements can cause localized bone loss (osteolysis) that mimics the appearance of aggressive bone cancer on medical imaging. This case series highlights the importance of recognizing this benign "mimic" to prevent patients from undergoing unnecessary, invasive biopsies and high-stress diagnostic workups.

What Problem Does This Paper Address?

In total hip replacements (THR), surgeons often use "cement restrictors"—small plugs inserted into the femoral medullary canal—to ensure bone cement stays pressurized around the prosthetic stem. While some restrictors are made of plastic or metal, others are biodegradable.

The challenge is that as these biodegradable plugs (such as the OptiPlug or SynPlug) break down over several years, they can trigger a localized inflammatory response that eats away at the surrounding bone. On an X-ray or MRI, this appears as a "lytic lesion"—a dark, expanding hole in the bone. Because these lesions grow slowly over time and can even erode the bone's outer shell (cortical scalloping), they look remarkably similar to metastatic cancer or multiple myeloma. This paper addresses the diagnostic pitfall of mistaking a routine implant degradation process for a life-threatening malignancy.

Methods

The authors present a clinical case series involving two elderly patients (ages 81 and 91) who presented with hip pain years after their initial surgeries. The study utilizes a multi-modal diagnostic approach to analyze the lesions:

  • Imaging: X-ray, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI) to assess the morphology and signal characteristics of the bone voids.
  • Biochemical Screening: Myeloma screens and inflammatory marker tests to check for systemic signs of cancer.
  • Nuclear Medicine: Bone scintigraphy (bone scans) to check for metabolic activity (uptake) that usually indicates a tumor.
  • Histopathology: In one case, a core biopsy was performed using an 8-gauge Jamshidi needle to provide a definitive tissue diagnosis.

Datasets

As this is a clinical case series, it does not use a large-scale computational dataset. Instead, it relies on the longitudinal medical records and imaging archives of two specific patients treated at the Royal Orthopedic Hospital in Birmingham, UK.

Key Insights and Ideas

  • The "Location" Signature: A crucial distinguishing feature of this entity is its consistent location. These lesions always appear at the distal tip of the prosthetic femoral stem—exactly where the restrictor plug is placed during surgery.
  • Temporal Lag: Unlike some surgical complications that appear immediately, this osteolysis doesn't show up on post-operative X-rays. It typically begins around two months after surgery and progresses slowly over a decade or more.
  • The Mimicry of Malignancy: The paper notes that these lesions can appear "expansile" and cause "endosteal scalloping." In the world of radiology, these are usually "red flag" descriptors for aggressive tumors, which is why these benign cases are so easily misidentified.
  • Biochemical Red Herrings: In the second case, the patient had unrelated abnormal proteins in her urine (polyclonal Kappa light chains). This biochemical finding, combined with the bone lesion, created a "perfect storm" of evidence that strongly suggested multiple myeloma, despite the lesion actually being benign.

Key Results

  • Case 1: An 81-year-old female showed an enlarging lytic lesion 11 years post-surgery. Despite negative cancer screens, the growth was concerning enough to warrant a biopsy. The histology revealed only non-specific inflammatory cells and no evidence of malignancy, confirming the lesion was a reaction to the degradable plug.
  • Case 2: A 91-year-old female showed a similar lesion 13 years post-surgery. By comparing current X-rays to those taken 12 years prior, doctors noted the lesion had been present and stable for over a decade. This long-term stability, combined with the specific location at the stem tip, allowed the team to diagnose it as restrictor-related osteolysis and avoid an invasive biopsy.
  • Diagnostic Rule: The authors conclude that if a lytic lesion is found specifically at the tip of a femoral stem in a patient with a prior THR, biodegradable restrictor-induced osteolysis should be at the top of the differential diagnosis list.

Limitations and Future Work

The primary limitation is the small sample size (two cases), which is typical for a case series intended to highlight a specific diagnostic pitfall rather than provide statistical prevalence.

The authors suggest that better documentation in operative records regarding the specific brand and material of cement restrictors used would be invaluable for radiologists years down the line. Future work could involve larger retrospective studies to determine the exact incidence of this phenomenon and whether specific materials (like Polylactic Acid vs. other polymers) carry a higher risk of mimicking malignancy.

Summary updated

Abstract

Peri-prosthetic osteolysis is a well-documented complication of total hip arthroplasty. A lesser-known form of peri-prosthetic osteolysis occurs specifically involving biodegradable cement restrictor devices which may be used in total hip replacements (THRs) to contain the cement material within the femoral medullary canal, which would help maintain adequate pressurization within the canal and secure the prosthetic femoral stem. The device is inserted into the femoral medullary canal just distal to the prosthetic stem. Different types of restrictors are used; certain biodegradables forms of restrictors are known to cause progressive osteolysis at the site of insertion, which can present as a gradually enlarging focal lytic lesion on imaging. While this entity as well as its relevance as a risk factor for peri-prosthetic fracture has been discussed in existing literature, the resemblance of this entity to a neoplastic process, particularly given the gradual enlargement over time is not well-documented. Understanding this process and potential pitfall when interpreting imaging, particularly X-rays, in patients who have previously undergone a THR, is important to avoid misdiagnosis of this otherwise benign entity as a neoplastic process and would potentially negate the need for unnecessary investigations.
BibTeX
@inproceedings{ariyaratne2024osteolytic,
  author = {Sisith Ariyaratne and Mark Davies and Scott Evans and Steven James and Rajesh Botchu},
  title = {{Osteolytic change surrounding biodegradable cement restrictors used in total hip replacements mimicking malignancy}},
  booktitle = {Indian},
  year = {2024},
  doi = {10.25259/ijmsr\_50\_2023},
}
Figure